Company Announcements Abcam established direct service in Australia and New Zealand in August. In September, Abcam announced that Peter Keen will not seek reelection to its Board. Abcam entered into an exclusive license, supply and distribution agreement with Australia’s Children’s Cancer Institute for multidrug-resistance protein 4 inhibitors, Ceefourin 1 and Ceefourin 2. Nirmidas Biotech raised […]
Company Announcements As part of its 2014–17 medium-term management plan, Takara Bio announced fiscal 2017 sales targets for its Research Reagents business of ¥18,708 million ($184 million) and ¥2,681 million ($26 million) for its Scientific Instruments business to make up 74% and 11% of Bioindustry segment sales, respectively. GTCR completed its acquisition of Cole-Parmer (see […]
Company Announcements Emulate launched in July a $12 million Series A financing to commercialize its “Organs-on-Chips” platform. The Boston Business Journal reported in July that PathoGenetix, which was developing its Genome Sequence Scanning technology for pathogen detection in food, filed for Chapter 7 bankruptcy. In August, Blacktrace Holding, which owns Dolomite Microfluidics and Syrris, licensed […]
Company Announcements Agilent Technologies agreed in June to distribute Cerno Bioscience’s MassWorks calibration and analysis software with all Agilent GC/MSD systems. The technology increases the mass accuracy of Agilent’s single-quadrupole GC/MSD to enable unknown-compound identification. In August, Agilent Technologies and Shimadzu released each other’s GC instrument control for their respective chromatography data systems (CDSs). INFICON’s […]
Company Announcements In October, investment firm Rangatira increased its stake in Magritek from 12% to 18%. Product Introductions Magritek introduced in July Spinsolve Phosphorus, calling it the world’s first phosphorus-31–capable benchtop NMR spectroscopy system. Oxford Instruments and Green Imaging Technologies launched the P5 Cell for high-pressure and -temperature studies of petroleum-reservoir rock core plugs. It […]
Company Announcements AB SCIEX and Dalton Pharma Services announced in August a research collaboration to develop antibody-drug-conjugate–analysis capabilities. Tecan announced in August a comarketing agreement with RECIPE Chemicals and Instruments for automation of LC/MS/MS IVD kits. Microsaic Systems selected Plexus to provide manufacturing solutions for its 4000 MiD system. Microsaic Systems announced its first OEM […]
Company Announcements Roche and the Garvan Institute of Medical Research announced in August a collaboration to develop new technologies for targeted epigenomic analysis. New England Biolabs exclusively in-licensed rights from Genomic Health to technology for the depletion of abundant DNA using RNase H–based depletion. Product Introductions In August, Coveris launched the micro TUBE LV for […]
Coinciding with ASHG 2014, several firms announced new partnerships in highly competitive markets. Affymetrix announced a multiyear supply agreement with Arosa Diagnostics, which will use Affymetrix instruments and arrays as part of its Harmony noninvasive prenatal test for Trisomy 21 in fetuses, allowing wider adoption of the test. Arosa’s DANSR (Digital Analysis of Selected Regions) […]
Company Announcements In June, John Wiley & Sons acquired SimBioSys, a provider of scientific-software tools that facilitate the drug-discovery process and a pioneer in the field of computer-aided retrosynthetic analysis. Cresset appointed CloudScientific as a Chinese distributor in July. Syapse raised $10 million in Series B financing, led by Safeguard Scientifics. Simulations Plus agreed in […]
Company Announcements Trinean named Chris van Ingen, a director at Bruker, Promega and ProteinSimple, to its Board in May. Sigma-Aldrich SAFC Commercial’s solid-state R&D business, Pharmorphix, entered into a collaborative technology agreement with BioTools. Rabo Capital acquired Kipp & Zonen, a provider of instruments for measuring solar radiation and atmospheric properties, in May. CEO Ben […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
